Dow Jumps 210 Points On Vaccine News From AstraZeneca

Video Credit: Wochit News
Published on November 23, 2020 - Duration: 00:37s

Dow Jumps 210 Points On Vaccine News From AstraZeneca

On Monday, US stocks rose.

AstraZeneca said its COVID-19 vaccine candidate demonstrated an average efficacy rate of 70%.

This is the third COVID-19 vaccine said to have surpassed the Food and Drug Administration's requirement of 50% effectiveness.

S&P 500: 3,580.82, up 0.7% Dow Jones industrial average: 29,473.41, up 0.7% (210 points) Nasdaq composite: 11,929.04, up 0.6%


You are here

Related videos from verified sources

Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval 01:03
Video credit: Wibbitz Top Stories - Published on November 30, 2020 

Covid-19 vaccine to be distributed initially in India says Serum Institute CEO 01:28
Video credit: Newsflare STUDIO - Published on November 29, 2020 

Oxford Astra Zeneca's vaccine error | What happens to India trials? | Oneindia News 01:25
Video credit: Oneindia - Published on November 27, 2020 

You might like